
Investing in a trusted Cardiac Diabetic Product List in India reflects one of the most resilient segments of the pharma industry that can give you endless profits. In this changing lifestyle and eating habits, the issues related to cardiovascular health are drastically increasing. These factors highly contribute to boosting the market size for cardiac diabetic products in India.
Table of Contents
ToggleAccording to IBEF’s stated data in September 2025, it has been seen that there is a strong demand for cardiac and antidiabetic medications. Both these markets are growing at a CAGR of 13% and 9%, respectively. Therefore, for pharma professionals, this niche offers a wide scope for portfolio expansion and overall outcomes.
So, for those who are planning to jump into this segment, Biofield Pharma is here to add significant value. Backed by over two decades of formulation expertise, our company has launched a specialised division named Biorise, offering a premium Cardiac Diabetic Product List in India. Dive deeper into this blog and learn valuable insights into how our company can be an ideal choice for the PCD Franchise journey in cardiovascular drugs.
The numbers behind this segment are not just impressive on paper. They reflect a genuine, growing public health need.
Put together, these numbers explain why cardiac and diabetic drugs consistently rank among the most prescribed medicines in India.
Cardiac medicines are used to manage conditions related to the heart and blood vessels, such as high blood pressure, high cholesterol, angina, and the risk of heart attack or stroke. Diabetic medicines help regulate blood sugar levels in people with type 1 or type 2 diabetes.
The reason these two categories are so often grouped together is not a marketing choice. Diabetes and cardiovascular disease frequently occur side by side. High blood sugar damages blood vessels over time, and people with diabetes are significantly more likely to develop hypertension, high cholesterol, and heart disease. Because of this overlap, most patients on long-term diabetes treatment eventually need cardiac medication too, and vice versa.
That is exactly why pharmaceutical companies like Biofield Pharma put both categories under a single division. It allows a distributor or franchise partner to serve one set of doctors, such as cardiologists, diabetologists, and general physicians. Here’s a look at Biofield Pharma’s current Cardiac Diabetic Product List in India:
| Brand Name | Composition | Packaging |
|---|---|---|
| Amlogiv-M/25 | Amlodipine 5 Mg + Metoprolol Succinate 25 Mg Tablets | 10*10 Alu Alu |
| Amlogiv-M/50 | Amlodipine 5 Mg + Metoprolol Succinate 50 Mg Tablets | 10*10 Alu Alu |
| Etorcut 10 | Atorvastatin 10 Mg Tablets | 10*10 Alu Alu |
| Etorcut 20 | Atorvastatin 20 Mg Tablets | 10*15 Alu Alu |
| Beterpine-10 | Cilnidipine 10 Mg Tablets | 10*10 Alu Alu |
| Beterpine 20 | Cilnidipine 20 Mg Tablets | 10*10 Alu Alu |
| Amlogiv 2.5 | Amlodipine 2.5 Mg Tablets | 10*10 Blister |
| Amlogiv 5 | Amlodipine 5 Mg Tablets | 10*10 Alu Alu |
| Amlogiv At | Amlodipine 5 Mg + Atenolol 50 Mg Tablets | 10*10 Alu Alu |
| Etorcut C | Atorvastatin 10 Mg + Clopidogrel 75 Mg Tablets | 10*10 Alu Alu |
| Etorcut-C-20 | Atorvastatin 20 Mg + Clopidogrel 75 Mg Tablets | 10*10 Alu Alu |
| Etorcut F | Atorvastatin 10 Mg + Fenofibrate 160 Mg Tablets | 10*10 Alu Alu |
| Cletiway 75 | Clopidogrel 75 Mg Tablets | 10*15 Blister |
| Cletiway-A | Clopidogrel 75 Mg + Aspirin 75 Mg Tablets | 10*10 Strip Pack |
| Elsorite 20 | Olmesartan 20 Mg Tablets | 10*10 Alu Alu |
| Elsorite-H | Olmesartan 20 Mg + Hydrochlorothiazide 12.5 Mg Tablets | 10*10 Alu Alu |
| Elsorite A | Olmesartan 20 Mg + Amlodipine 5 Mg Tablets | 10*10 Alu Alu |
| Crestofine 20 | Rosuvastatin 20 Mg Tablets | 10*10 Alu Alu |
| Crestofine C-10 | Rosuvastatin 10 Mg + Clopidogrel 75 Mg Tablets | 10*10 Alu Alu |
| Crestofine-Gold 10 | Rosuvastatin 10 Mg + Clopidogrel 75 Mg + Aspirin 75 Mg Capsules | 10*15 Strip Pack |
| Crestofine C-20 | Rosuvastatin 20 Mg + Clopidogrel 75 Mg Capsules | 10*10 Alu Alu |
| Crestofine-F | Rosuvastatin 10 Mg + Fenofibrate 160 Mg Tablets | 10*10 Alu Alu |
| Crestofine-F | Rosuvastatin 20 Mg + Fenofibrate 160 Mg Tablets | 10*10 Alu Alu |
| Telsicap C | Telmisartan 40 Mg + Cilnidipine 10 Mg Tablets | 10*10 Alu Alu |
| Telsicap Am | Telmisartan 40 Mg + Amlodipine 5 Mg Tablets | 10*10 Alu Alu |
| Telsicap H | Telmisartan 40 Mg + Hydrochlorothiazide 12.5 Mg Tablets | 10*10 Alu Alu |
| Telsicap H 80 | Telmisartan 80 Mg + Hydrochlorothiazide 12.5 Mg Tablets | 10*10 Alu Alu |
| Telicap Ah | Telmisartan 40 Mg + Amlodipine 5 Mg + Hydrochlorothiazide 12.5 Mg Tablets | 10*10 Alu Al |
Cardiac and diabetic conditions are chronic, which means patients typically stay on medication for years, sometimes for life. That leads to repeat prescriptions and far higher patient retention compared to segments treating short-term, acute conditions. Add to that the fact that multiple types of specialists, like cardiologists, endocrinologists, diabetologists, and general physicians. All prescribe from this category, and you get a much wider prescriber base than most other therapeutic segments offer.
India’s ageing population and its rising rates of lifestyle disorders only add to this. As more people move toward sedentary jobs, processed food, and high-stress routines, the number of people needing long-term cardiac and diabetic care is only expected to grow.
Biofield Pharma brings over 25 years of formulation experience to the table. We have built our portfolio specifically around cardiac and diabetic care. Our product portfolio is large enough to give you real flexibility in building your own range, and we run our franchise model on an ethical, transparent basis rather than aggressive short-term sales tactics.
Beyond the product list itself, you will get fast delivery, monopoly rights in your chosen territory, and dedicated marketing support. Additionally, you will get consistent stock availability, so you are never left explaining delays to your doctors and distributors.
Not every product listed on the market is worth investing in. Before you commit to a company, it’s worth checking a few things carefully:
WHO-GMP Manufacturing – ensures the products are made under globally recognised quality standards
DCGI-Approved Formulations – confirm the products are legally cleared for sale in India
Product Availability – a company should be able to fulfil orders consistently, without long gaps
Packaging Quality – good packaging protects the medicine and builds trust with doctors and patients
Monopoly Rights – protect your territory from internal competition
Competitive pricing – keeps your margins healthy without pricing yourself out of the market
Marketing Support – visual aids, samples, and promotional material that make your job easier on the ground
Biofiled Pharma checks all of these boxes and gives you a far stronger foundation than one offering low prices alone.
Saying “WHO-GMP certified” is easy. Actually living up to it requires a lot of effort. We start our manufacturing process by sourcing good-quality raw materials from verified suppliers. Every batch we manufacture is made with pure and verified material. From there, our products go through proper testing to check potency, purity, and consistency. Our quality assurance team reviews each stage of production. Additionally, we carry out the stability testing to confirm that products retain their effectiveness across their shelf life.
At Biofield, packaging standards are treated as part of quality. We provide different types of packaging options such as alu-alu and blister packs. You can choose your packing option according to your requirements. And throughout, our regulatory compliance team ensures every product meets DCGI norms before it ever reaches a franchise partner.
We have a simple process to join our cardiac diabetic PCD franchise. Here is a proper guide:
Contact Biofield Pharma – You can reach out to our team to discuss the segment you want to start and your goals.
Share Your Documents – You have to submit the basic paperwork required to verify your business
Choose Your Product Range – select the formulations and combinations that suit your target market
Get Monopoly Rights – You have to provide information about the territory you want to start in so you can operate without internal competition
Start Distribution – Operations of your franchise start with building relationships with doctors and stocking your network
There are some advantages of partnering with us. Let’s discuss:
A good product range can not do well without the right support to promote it. This is why Biofiled Pharma invests in extensive promotional material for every partner. We provide the following promotional support for our partners:
This support is design to reduce the burden on you as a franchise partner. With this, you can focus on building relationships in the market.
If you want to start your own franchise in the cardiac and diabetic segment, then you need a set of documents. Every document serving a specific legal purpose:
Biofield Pharma has an established presence across India. We offer area-wise business rights so partners can grow without stepping on each other’s areas. Whether you are looking to build a presence in rural or semi-urban markets, or want to establish yourself in a well-developed urban centre, we work with you to find a territory that fits your goals.
Some of the locations currently available for a monopoly-based cardiac diabetic franchise include:
Delhi
Punjab
Tamil Nadu
Goa
Haryana
Chandigarh
Uttar Pradesh
Biofield Pharma offers an extensive and well-formulated product portfolio, timely and consistent delivery, and ethical business practices built for long-term partnerships. We have WHO-GMP-backed manufacturing quality, transparent pricing with no hidden surprises, genuine monopoly rights, and hands-on marketing support. Our team has years of experience in this industry, and we help you with our guidance at every step.
The cardiac diabetic segment is not a passing trend. It is depend to how India’s health patterns are changing, and that shift is not reversing soon. For pharma professionals looking for a stable, long-term business opportunity, this is one of the strongest segments to build in.
Ready to bring your entrepreneurial energy into a segment with genuine, lasting demand? Get in touch with Biofield Pharma and take the first step toward a Cardiac Diabetic Product List in India that’s built to last.
Address – SCF 466, First Floor, Sector 13, Chandigarh 160101
Mobile Number – +91-9888421594 or +91-7743005525
Email – connect.biofield@gmail.com
